Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response.
暂无分享,去创建一个
[1] J. Steinke,et al. 2. Cytokines and chemokines. , 2003, The Journal of allergy and clinical immunology.
[2] K. Engström,et al. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving , 2003, Scandinavian cardiovascular journal : SCJ.
[3] A. Larsson,et al. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. , 2002, The Journal of thoracic and cardiovascular surgery.
[4] C. Triggs,et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. , 2002, The Journal of thoracic and cardiovascular surgery.
[5] J. Pincemail,et al. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit , 2002, Perfusion.
[6] T. Yau,et al. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[7] J. Murkin. Attenuation of neurologic injury during cardiac surgery. , 2001, The Annals of thoracic surgery.
[8] V. Richard,et al. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement , 2001, Fundamental & clinical pharmacology.
[9] J. Hammon,et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. , 2000, The Annals of thoracic surgery.
[10] Schmucker,et al. Perioperative serum levels of tumour‐necrosis‐factor alpha (TNF‐α), IL‐1β, IL‐6, IL‐10 and soluble IL‐2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution , 1999, Clinical and experimental immunology.
[11] G. Tangen,et al. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance. , 1999, The Journal of thoracic and cardiovascular surgery.
[12] W. Reents,et al. Influence of different autotransfusion devices on the quality of salvaged blood. , 1999, The Annals of thoracic surgery.
[13] S. Zahler,et al. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. , 1999, Cardiovascular research.
[14] D. Reboussin,et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. , 1998, The Annals of thoracic surgery.
[15] J. Vincent,et al. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. , 1997, Chest.
[16] W. van Oeveren,et al. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. , 1995, The Annals of thoracic surgery.
[17] S Westaby,et al. Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[18] W. van Oeveren,et al. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. , 1992, The Annals of thoracic surgery.
[19] Xiang Xiaoyong,et al. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .
[20] Larry Borish,et al. Cytokines and chemokines , 2003 .
[21] W. van Oeveren,et al. Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit. , 1996, The Journal of thoracic and cardiovascular surgery.